FINWIRES · TerminalLIVE
FINWIRES

DRI Healthcare Trust Price Targets Raised at RBC, CIBC

By

Analysts at RBC Capital Markets and CIBC Capital Markets raised their price targets on DRI Healthcare Trust (DHT-UN.TO) to CA$22 from CA$21, and to CA$21.50 from CA$21, respectively.

RBC analyst Douglas Miehm maintained an outperform rating on shares of the pharmaceutical royalty company while CIBC analyst Erin Kyle maintained an outperformer rating on DRI.

"We see upside to our return profile and NAV estimate depending on the pace of commercialization, which may exceed consensus estimates, and on the timing of cumulative sales milestone payments," Kyle said in a note to clients.

What else is happening in Research?

Research

Lake Street Downgrades Priority Technology to Hold From Buy, $8.05 Price Target

Priority Technology (PRTH) has an average rating of buy and mean price target of $10.80, according to analysts polled by FactSet.Price: $7.76, Change: $+1.93, Percent Change: +33.10%

$PRTH
Research

Tecsys Price Target Raised to CA$46.00 at ATB

ATB Cormark Capital Markets raised its price target on Tecsys Inc. (TCS.TO) to CA$46.00 from CA$41.00 on Monday.Analyst Gavin Fairweather maintained an outperform rating on shares of the enterprise supply-chain management software company."Last week, we attended meetings with TCS CEO Peter Brereton and institutional investors," Fairweather said in a note to clients."The interactions reinforced our view that strengthening bookings, growth and margins are durable trends over our forecast horizon," the analyst said.

$TCS.TO
Research

Deutsche Bank Kicks Off Vincorion Coverage at Buy

Deutsche Bank on Monday initiated the coverage of German defense and security systems developer Vincorion (V1NC.F) with a buy rating and a price target of 26 euros.

$V1NC.F